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Abstract
Aim: Resuscitative endovascular balloon occlusion of the aorta (REBOA) during cardiopulmonary resuscitation (CPR) increases coronary and cerebral
perfusion pressure, which might improve neurologically intact survival after refractory cardiac arrest. We investigated the feasibility of REBOA during
CPR in the emergency department.
Methods: Patients in refractory cardiac arrest not qualifying for extracorporeal CPR were included in this pilot study. An introducer sheath was placed by
ultrasound-guided puncture of the femoral artery, and a REBOA catheter was advanced to the thoracic aorta in 15 patients undergoing CPR.
Primary outcome was correct placement within 10 min of skin disinfection. Secondary outcomes included perfusion markers (mean central arterial blood
pressure, end-tidal CO2, non-invasively measured cerebral oxygenation) and procedural information (number and duration of attempts, complications,
verification of correct position and occlusion).
Results: Successful catheter placement was achieved in 9 of the 15 patients (median 9 min 30 s). Median interval from dispatch to start of the procedure
was 59 min. A small, albeit significant increase in non-invasively measured cerebral oxygenation was found, but none in blood pressure or end-tidal CO2.
However, two patients with pulseless electrical activity of more than 20 min achieved return of spontaneous circulation immediately after REBOA.
Conclusion: In this pilot trial, REBOA during CPR was successful in 60% of attempts. Long resuscitation times before start of the procedure might
explain difficult insertion and missing effects. Nevertheless, insertion of REBOA in patients suffering from non-traumatic cardiac arrest is feasible and
might increase coronary and cerebral perfusion pressures and perfusion.
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Introduction
Every year, 510 of every 10 000 citizens suffer from sudden out-of-
hospital cardiac arrest (OHCA) with a survival rate of about 10%.15
Since heart and brain depend on adequate perfusion, irreversible
damage after cardiac arrest (CA) occurs within minutes.6 Chest
compressions are intended to restore perfusion to these vital organs
but achieve only about 30% of normal coronary or cerebral perfusion.7
During cardiopulmonary resuscitation (CPR), coronary perfusion
pressure predicts return of spontaneous circulation (ROSC) and
survival.8 Cerebral perfusion pressure is crucial for a good
neurological outcome.6
Therefore, improving coronary and cerebral perfusion pressure
might increase survival with favourable outcome after CA. Occlusion
of the descending aorta increased carotid and coronary artery blood
flows and perfusion pressures in animal CA models,914 which led to
improved ROSC and better 48-h survival and neurological function.12
16 In humans, occlusion of the descending aorta has mostly been
performed together with open-chest CPR in the trauma population,
with no clear evidence of superiority of the open-chest approach
compared to standard CPR.17
Recently, balloon occlusion of the aorta in trauma (REBOA,
resuscitative endovascular balloon occlusion of the aorta) has
emerged as an alternative to surgical cross-clamping of the aorta
in exsanguinating trauma patients,18 and REBOA placement is
feasible with ultrasound.19,20 Reports of severely injured patients who
arrested during or immediately before REBOA-catheter placement
demonstrated improved blood pressure in the upper body.21
Furthermore, retrospective comparisons of REBOA versus thoracot-
omy from trauma registries suggest that REBOA is usually faster and
at least as effective as (if not superior to) thoracotomy and open- chest
CPR for trauma patients in or near cardiac arrest.22,23
This pilot study aimed to investigate the feasibility of ultrasound-
facilitated REBOA-catheter placement during CPR in the everyday
setting of the emergency department of a university hospital.
Methods
The study was registered at ClinicalTrials.gov (NCT03664557). The
Bern Cantonal Ethics Committee (Kantonale Ethikkommission Bern,
Nr 2018-00741, 30/AUG/2018) approved this study and mandated a
study-independent physician as a safeguard for each patient until a
deferred informed consent could be obtained from survivors or next of
kin. Deferred informed consent was waived by the ethics committee
for non-survivors to avoid additional burden on relatives who had
already suffered the loss of a loved one. An independent Data Safety
and Monitoring Board reviewed the first 5 patients and reported results
to the ethics committee after the 1st, 2nd and 5th patient.
We included patients suffering from refractory CA who failed
ROSC after 10 min of high-quality advanced life support. Patients
were excluded for any of the following reasons: qualifying for the local
extracorporeal CPR (e-CPR) program, age <18 years, pregnancy,
presence of upper body/torso trauma or known aortic aneurysm, both
femoral arteries unable to accommodate a 7Fr introducer sheath,
available written advanced directives excluding CPR, or study
personnel/equipment being unavailable.
CA victims were transported by the local emergency medical
service under continuous mechanical CPR to the university hospital.
Inclusion took place in the emergency department after reassessment
by the study-independent physician and the emergency team on duty.
After study inclusion under continuous mechanical CPR, the senior
intensivist on duty punctured the femoral artery with ultrasound
guidance. Before a 25-cm-long 7F introducer (Radifocus Introducer II,
Terumo Europe, Leuven, Belgium) was inserted, the emergency
physician on duty verified correct arterial placement of the guidewire
by abdominal ultrasound. The ultrasound showed either the guidewire
in the abdominal aorta or the lack of guidewire in the inferior vena cava
at the confluence with the hepatic veins. REBOA was aborted if the
placement procedure took more than 20 min or if more than 3
unsuccessful puncture attempts or guidewire and sheath insertion
attempts occurred.
After successful introducer placement, continuous invasive
pressure monitoring started simultaneously at the tip of the
catheter and at the side port of the introducer. The catheter
(ER-REBOA; Prytime Medical, Boerne, TX, USA) was inserted and
advanced into the thoracic aorta at the 4th intercostal space. The
catheter's balloon was filled with NaCl 0.9% until pulsatility of the
pressure trace distal to the occlusion at the side port of the
introducer disappeared, or the maximal filling volume of 24 ml was
reached. The study period ended 10 min after balloon inflation, at
which point the emergency team re-evaluated the patient's situation
and made a decision on further therapeutic options, including
stopping resuscitative efforts.
Blood pressure at both the catheter tip and side port, heart rate and
end-tidal CO2 were recorded in the local anaesthesia information
system (Philips Intellivue MP5, Philipps Healthcare Switzerland, and
COPRA System GmbH, Berlin, Germany) every 1 min. Non-invasive
measurement of cerebral oxygenation was performed bilaterally on
the forehead (NONIN SenSmart1 Model X-100 with internal storage,
NONIN Europe, Tilburg, The Netherlands) and recorded before
REBOA occlusion and 1, 5 and 10 min after.
Because of a lack of previous data, we chose a convenience
sample of 15 patients. For this small data set we did not test for
normality and used non-parametric tests. Median and interquartile
range are the descriptive statistics. Repeated measurements were
analysed with the Friedmann test (GraphPad Prism Version 8;
GraphPad Software, San Diego, CA, USA). Data are presented as
percentages or median and interquartile range. A P level of <0.05 is
considered significant.
Results
Overall, successful catheter placement was achieved in 9 patients
(60%; Tables 1 and 2). Median time to balloon inflation was 9 min 30 s
(range 8 min 32 s13 min). In 6 patients, inflation was achieved within
10 min. In the remaining 3 patients the procedure was prolonged. In
one patient (patient 2; Tables 1 and 2) it took 18 min because the
guidewire was initially placed in the vein twice, which was detected
through sonographic visualization of the guidewire in the inferior vena
cava. In another patient we were unable to advance the guidewire
despite appropriate aspiration of blood and a second puncture was
needed (14 min, patient 5, Tables 1 and 2). In an obese patient
ultrasound visualization of the guidewire was unsuccessful and led to
an insertion delay of 13 min (patient 3; Tables 1 and 2).
In 3 patients (patients 6, 8, 10; Tables 1 and 2), puncture attempts
were abandoned after reaching the time limit or when more than 3
unsuccessful attempts were performed. In all three of these cases,
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Table 1 – Details on REBOA insertion in the individual patients.
Patient REBOA insertion Time to
inflation (min:s)
Ultrasound inferior
vena cava
Ultrasound
abdominal aorta
Blood pressure (mmHg)
from sheath before inflation
Remarks
1 Success 8:32 Wire absent Insufficient quality 83/21 
2 Success, after 2 ve-
nous puncture
18:00 Wire 2 in inf. v. cava Wire identified on 3rd
attempt
80/25 2 venous puncture, identified by guidewire in inf. v.
cava during ultrasound
3 Success 13:00 Insufficient quality, wire
absent
Insufficient quality 33/5 Time to inflation prolonged because correct placement
difficult to confirm by ultrasound (obesity), and diastolic
blood pressure only 5mmHg
4 Success 8:00 Wire absent Not done 64/30 —
5 Success 14:00 Wire absent Insufficient quality Damped curve Time to inflation prolonged because guidewire could not
be advanced after 1st puncture, and difficult confirma-
tion after 2nd puncture
6 Failure n/a n/a n/a Puncture failed 3
7 Venous insertion
(unnoticed)
Insufficient quality, wire
absent
Insufficient quality 67/5 Guidewire could not be advancedafter 1st puncture, and
difficult confirmation after 2nd puncture. Although
diastolic blood pressure was low, decision was made to
move on
8 Failure Wire absent Wire absent n/a Guidewire could be advanced in the 2nd attempt only,
but sheath could not be advanced. Abortion of attempt
after 18min
9 Success 10:00 Not documented Not documented Not measured —
10 Failure n/a n/a n/a Puncture failed 3
11 Success 6:05 Not documented Wire identified 28/20 
12 Success 9:30 Wire absent Wire identified Not measured 
13 Arterial sheath directed
caudally (unnoticed)
Wire absent Wire absent 60/25 Difficult anatomical landmarks because of large scrotal
hernia. Although wires not visible in aorta, high diastolic
blood pressure made intraarterial position likely. X-ray
confirmed caudal position
14 Venous insertion
(unnoticed)
Wire absent Wire absent 38/0 Ultrasound equivocal: wire absent in both vessels.
Decision to advance despite low diastolic pressure. X-
ray confirmed venous position
15 Success 9:00 Wire absent Not done Not measured 
Note. REBOA: resuscitative endovascular balloon occlusion of the aorta.
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CPR was discontinued because more than 60 min of CPR time had
elapsed.
In one patient (patient 13; Tables 1 and 2) with a large scrotal
hernia, arterial puncture could be achieved but the sheath and REBOA
catheter were directed caudally, which was noticed only after an
attempt to inflate the balloon. Obesity and difficult anatomy made
ultrasound challenging, and diastolic blood pressure correctly
indicated intraarterial position.
In 2 patients, the REBOA catheter was erroneously placed
venously (patients 7, 14; Tables 1 and 2). In both cases, ultrasound
could not confirm the guidewire within the aorta but it could not be
detected in the vena cava either, yet the diastolic pressure below
10 mmHg at the side port of the sheath pointed toward a venous
position. Since one previous patient (patient 3) with successful
insertion also had very low diastolic pressure, uncertainty during the
attempt persisted. The procedure was continued, resulting in venous
misplacement of the catheter, which was confirmed only later by chest
radiograph.
In 2 patients with a relatively short duration of CPR, ROSC was
achieved immediately after the REBOA balloon was inflated.
Unfortunately, both patients died, one after deflation of the balloon
and the other after withdrawal of life sustaining therapy because of
hypoxic-ischemic encephalopathy. In one patient, the attempt to
ensure complete occlusion of the aorta by guiding the filling volume on
the basis of the pressure trace obtained from the sheath led to
overinflation and balloon rupture.
Regarding the secondary outcomes, a small, albeit significant
increase could only be detected for cerebral oxygenation with near-
infrared spectroscopy (NIRS). End-tidal CO2 and blood pressure
remained unchanged (Table 3).
Discussion
This pilot study shows that REBOA during CPR is not easy to
accomplish but is feasible, as REBOA-catheter placement was
possible in 9 of 15 patients, and 2 patients temporarily achieved
ROSC. Although a 60% success rate seems low, we report, for the first
time, clinical application of REBOA under ongoing CPR in patients
with prolonged advanced life support.
Arterial puncture and ultrasound-confirmed correct catheter
placement during resuscitation efforts are challenging. Ultrasound
examinations are difficult as ongoing CPR moves the chest and
abdomen, and ultrasound image quality is poor due to gastric and
intestinal air from prior bag-mask ventilation. This often leads to
unreliable confirmation of the correct guidewire position. In 1 of 3
Table 3 – Secondary outcomes: changes in cerebral oxygenation measured by NIRS, MAP proximal to the occlusion
and end-tidal CO2.
Outcome Before occlusion After occlusion 1 min 5 min 10 min
NIRS (%) 41 (2158) 41 (2462) 41 (3363) 41 (3468) 42 (3168) P < 0.001
MAP (mmHg) 39 (2255) 44 (1976) 45 (2181) 43 (2160) 37 (1767) P = 0.08
End-tidal CO2 (mmHg) 22 (1233) 20 (1233) 19 (1327) 17 (932) 14 (1127) P = 0.17
Note. All measurements are median and interquartile range (13). NIRS: near-infrared spectroscopy; MAP: mean arterial blood pressure; end-tidal CO2: end-tidal
carbon dioxide concentration.
Table 2 – Details of cardiac arrest circumstances.
Patient Success Interval dispatch
time to start of
procedure (min)
Witnessed
cardiac
arrest
First
documented
rhythm
Rhythm
before start
of procedure
Interval
collapse to
start of CPR
(min)
Bystander
CPR
ROSC
1 Yes 81 Yes Shockable (AED) PEA 0 Yes No
2 Yes 60 Yes VF PEA 0 Yes No
3 Yes 88 Yes VF PEA <1 Yes No
4 Yes 41 Yes VF Asystole 0 Yes No
5 Yes 32 Yes Asystole PEA 1 Yes No
6 No No sooner than 44 No VF PEA n/a No No
7 No (vein) 85 Yes PEA PEA 5 Yes No
8 No 107 Yes VF PEA 5 Yes No
9 Yes 26 Yes PEA 0 EMS Yes
10 No No sooner than 52 No VF Asystole n/a No No
11 Yes 58 Yes VF Asystole <1 Yes No
12 Yes 59 Yes VT PEA 7 Yes No
13 No (sheath directed caudally) 30 Yes VT VT 7 Yes No
14 No (vein) 128 Yes VF PEA 10 Yes No
15 Yes 40 Yes PEA PEA 14 No Yes
Note. ROSC: return of spontaneous circulation; AED: automatic external defibrillator; VF: ventricular fibrillation; VT: ventricular tachycardia (pulseless); PEA:
pulseless electrical activity; EMS: emergency medical service.
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patients with venous puncture (patient 2; Tables 1 and 2), ultrasound
confirmed venous guidewire position, thereby preventing inadvertent
balloon inflation in the vena cava and allowing for another puncture
attempt. In the 2 other patients (patients 7, 14) with unnoticed venous
misplacement, ultrasound was equivocal. The diastolic blood
pressure below 10 mmHg obtained from the sheath before catheter
insertion was suggestive of venous position when compared to the
findings in other patients with correct arterial placement, who in most
cases showed a diastolic blood pressure over 20 mmHg. However,
low blood pressure during CPR does not reliably exclude correct
arterial position, as seen in patient 3 (Tables 1 and 2).
Apart from confirmation of arterial position, palpation at the
contralateral artery or pressure monitoring at the introducer side port is
used to confirm complete aortic occlusion by the loss of pulsatile
pressure readings upon balloon inflation in the trauma setting.24 With
ongoing CPR this does not prevent overinflating the balloon: in one
patient, the REBOA-catheter balloon was inflated stepwise according
to the manufacturer's instructions with a 24-ml balloon-filling volume
(resulting in a diameter of 32 mm) but the balloon ruptured during intra-
aortal inflation. Later we discovered on a previously performed, 2-
year-old abdominal computerized tomography (CT) scan an aortic
diameter of 20 mm. After discussion with the manufacturer, the Data
Safety and Monitoring Board, and the Cantonal Ethics Committee, it
was agreed not to fill the balloon upon cessation of pulsatile pressure
trace obtained from the femoral artery. We agreed to a protocol
amendment limiting the balloon-filling volume to below the official
maximum (12 ml in women, 20 ml in men, corresponding to a 25- and
30-mm balloon diameter).
In one case the femoral artery was punctured correctly, but the
guidewire was unintentionally directed caudally, resulting in incorrect
femoral artery REBOA-catheter placement. The puncture was
technically difficult because of a large scrotal hernia, which may
have contributed to the misplacement. CPR was continued for 10 min
with the catheter left in place. Two minutes after balloon inflation,
mean arterial blood pressure dropped from 47 mmHg to 11 mmHg
without pulsatility. Five minutes after occlusion no blood pressure was
measurable. NIRS-detected cerebral oxygenation and end-tidal CO2
remained unchanged. After another 10 min of advanced life support,
the resuscitation team withdrew further CPR attempts as 59 min had
passed since a second CA after previous temporary ROSC, with no
reversible causes and no ventricular activity in transthoracic
echocardiography found. Radiologic control showed the catheter in
the right leg.
Interestingly, Brede et al.,25 recently showed correct and reliable
out-of-hospital arterial placement of such catheters in groin vessels
verified by sonography. Severe vasoconstriction due to high
cumulative doses of adrenaline and local haemostasis at the site of
insertion due to prolonged reduced blood flow may both explain why
earlier insertion as conducted by Brede et al. is more often successful
than later attempts. The feasibility of this out-of-hospital approach
needs to be confirmed in a larger study. Both, the study by Brede and
colleagues and our findings suggest that to generate evidence about
the effect of such a possibly lifesaving intervention, the REBOA
catheter should be used only in the setting of a randomised controlled
trial. Since early interventions seem to have higher success rates and,
at least theoretically, better outcomes, a future study might investigate
REBOA catheter placement by a dedicated pre-hospital emergency
team following a strict study protocol.
Coronary blood flow and coronary perfusion pressure (of at least
15 mmHg8) drive myocardial oxygen supply and are strong predictors
of ROSC and survival to hospital discharge.8,26 During CPR, coronary
perfusion pressure results from the difference between right atrial
pressure and aortal pressure during decompression. Increased
coronary and cerebral perfusion pressure and flows in animal models
have translated into improved rates of ROSC, 48-h survival and
neurological function.1216 Occlusion of the descending aorta in CA
animal models showed increases in coronary and carotid artery blood
flow, resulting in higher perfusion pressures.9,16 It has been
demonstrated in severely injured patients who arrested during trauma
resuscitation that in addition to temporary haemostasis distal to aortic
occlusion, the REBOA procedure improved upper body blood
pressure.21
This was reflected in the 2 patients with refractory CA and ROSC
immediately after REBOA. In both cases, traditional advanced life
support had failed to achieve sustained ROSC, and occlusion of the
aorta took place 37 and 49 min after the initial onset of arrest, a
duration of CPR usually associated with very poor chances of
ROSC.27,28
One patient (patient 15; Tables 1 and 2) with initial pulseless
electrical activity (PEA) had intermittent ventricular fibrillation and
defibrillation during transport. After 27 min of CPR, the REBOA
procedure was started. ROSC followed immediately after balloon
inflation and NIRS-detected cerebral oxygenation increased from no
measurable value to 72% right/74% left over the following 10 min. The
effect remained stable for the time the balloon remained inflated.
Transesophageal echocardiography and CT scanning revealed a
type A aortic dissection confined to the ascending aorta. The patient
remained haemodynamically stable (blood pressure 139/102 mmHg)
without inotropic support even under stepwise balloon deflation.
Unfortunately, a brain CT scan showed early and extensive hypoxic-
ischemic brain injury. Aortic surgery was postponed to allow
neurological evaluation, but the patient died 2 days later after life
support was withdrawn because of the extensive brain injury.
The other patient (patient 9; Tables 1 and 2) arrested with PEA
13 min after hospital admission because of severe dyspnoea. Multiple
Fig. 1 – Near infrared spectroscopy (NIRS) of patient 9:
during resuscitative endovascular balloon occlusion of
the aorta, there was an increase in cerebral oxygenation
from 53% to 80% and return of spontaneous circulation.
Deflation (*) caused a decrease in cerebral oxygenation,
and after the decision to withdraw further treatment
because of futility (**), the patient deteriorated and died.
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comorbidities excluded her from e-CPR. REBOA balloon occlusion
occurred another 23 min later, followed by immediate ROSC with
marked increase in NIRS-detected cerebral oxygenation from 53% to
80% (Fig. 1). After ruling out reversible CA causes, further
resuscitative measures were abandoned and the REBOA balloon
deflated. After deflation of the REBOA balloon, a decrease in blood
pressure and cerebral oxygenation occurred immediately, followed by
re-arrest 17 min later. Even though further therapy was withdrawn in
both patients due to lack of therapeutic options, the occurrence of
ROSC in these patients supports the pathophysiological concept and
findings in animal models regarding REBOA in CA.
Several factors might have been contributed to the major limitation
of this study: the high rate of incorrect catheter placement. First, our
local approach to OHCA includes EMS personnel judge whether they
can transport the patient in time for e-CPR to begin within 45 min.
Therefore, this study included only patients not qualifying for e-CPR
who had received prolonged advanced life support. CPR and skin
disinfection for the REBOA manoeuvre took about 59 min (41
88 min). In cases where REBOA was performed early, higher
sheath and catheter placement success rates were achieved. The
very long duration of CPR before the procedure started (due to the
study design) might have contributed to challenging REBOA place-
ments. This could be one explanation of the high success rate of early
out-of-hospital REBOA placement at the scene.25 The long duration
from CA to aortal balloon occlusion may also explain the minimal
observed effect on blood pressure proximal to the occlusion. After
more than 1 h of CPR, the increased acidosis and vasoplegia might
have impeded any detectable effects on blood pressure and end-tidal
CO2. The significant effect on NIRS-detected cerebral oxygenation is
most probably not clinically relevant in this setting.
Second, the critical care physician on call performed the REBOA-
catheter placement in this pilot study, as they are responsible for the
hospitals’ e-CPR interventions. Therefore, vascular access experi-
ence during CPR was given. The specific handling of the REBOA-
balloon-catheter was taught at the start of the study, but we should
have offered more brush-up sessions over the course of the study
period.
Third, an important factor influencing success is the clinical
environment and resuscitation team composition. At the Bern
University Hospital, e-CPR vascular cannulation is performed in
the hospital's coronary catheter suite or in the intensive care unit, not
in the emergency department. Performing an ultrasound-guided
femoral artery puncture during CPR in a busy emergency room is
challenging and puts special burdens on communication, procedural
skills and handling of equipment compared to the usual familiar
environment.
Team composition during the study was different from in the
standard e-CPR approach. The sole study intervention was restricted
to a small group of investigators, but the clinical resuscitation teams
were composed of the available on-call personnel on duty for the
emergency room and were not always the same people.
Summarizing our experience and in contrast to published evidence
in the trauma literature,24 in this pilot study, neither sonography nor
distal invasive blood pressure monitoring alone was reliable in
excluding misplacement of the REBOA catheter. Abdominal ultra-
sound can confirm position in the abdominal aorta or vena cava in case
of successful wire visualization, but acquisition of those images can be
difficult under CPR. When ultrasound is inconclusive, we suggest
adding blood pressure monitoring at the sheath, where a diastolic
blood pressure below 10 mmHg is suggestive of venous malposition.
Also unlike in a trauma setting, balloon filling based on palpation or
measurement of distal pulses carries the risk of balloon (rather than
aortic) rupture due to overinflation. Intrathoracic and intra-abdominal
pressure changes generated by CPR are possibly transmitted to the
femoral artery, without necessarily indicating blood flow. To our
knowledge, no data exist describing the direct correlation of palpable
femoral pulse and actual blood flow during CPR.
In conclusion, this pilot study showed that REBOA during
refractory CA under ongoing CPR is feasible, and REBOA-catheter
placement was successful in 60% of study patients. In 2 patients
ROSC occurred. An early REBOA procedure might increase success
rates. Therefore, structured repeated training over time for the
intervention team is crucial. Larger outcome studies need to define the
proper timing of the REBOA procedure in CA patients and its effects on
survival and the long-term neurological outcome.
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